Evotec - About the company
Evotec is a public company based in Hamburg (Germany), founded in 1993. It operates as an AI-driven life science company accelerating drug discovery and development. Evotec has raised $25.1M in funding.
Company Details
AI-driven life science company accelerating drug discovery and development. It is focused on pioneering drug discovery and preclinical development using advanced technologies, deep disease expertise, and integrated R&D platforms. It accelerates the creation of new therapies across modalities, including small molecules and biologics, to bring life-changing medicines to patients faster.
- Website
- www.evotec.com/
- Email ID
- *****@evotec.com
- Phone Number
- +49 **********
- Registered Address
- Essener Bogen 7, DE-22419 HAMBURG
Key Metrics
Founded Year
1993
Location
Hamburg, Germany
Stage
Public
Total Funding
$25.1M in 23 rounds
Latest Funding Round
Investors
Ranked
1st among 2 active competitors
Annual Revenue
€500M - €1B as on Dec 31, 2024
Employee Count
4,767 as on Jun 30, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with Evotec
Evotec is associated with 4 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Evotec SE CIN: K1101_HRB156381 , Germany, Active | Mar 29, 2019 | €500M - €1B (As on Dec 31, 2024) | - | |
Evotec International Gmbh CIN: HRB72242 , Germany, Active | Aug 18, 1999 | - | 252 (As on Dec 31, 2020) | |
EVOTEC INTERNATIONAL GMBH CIN: 831855142 , Norway, Active | May 24, 1999 | - | - | |
EVOTEC (US) INC. CIN: 943353740 , United States, Active | Dec 31, 1999 | - | 729 (As on Dec 31, 2024) | - |
Evotec's IPO details
Evotec got listed on Nov 10, 1999.
Click here to take a look at Evotec's IPO in detail
Sign up to download Evotec's company profile
Evotec's funding and investors
Evotec has raised a total funding of $25.1M over 23 rounds. Its first funding round was on Mar 29, 1998. Its latest funding round was a Grant (prize money) round on Jan 08, 2026 for $*****. 1 investor participated in its latest round. Evotec has 24 institutional investors.
Here is the list of recent funding rounds of Evotec:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 08, 2026 | 2363940 | Grant (prize money) | 6572830 | 9002882 | 4941896 | 4260625 |
May 08, 2025 | 5484022 | Grant (prize money) | 5582196 | 7915831 | 9979784 | |
Apr 11, 2025 | 8845479 | Grant (prize money) | 3128687 | 6898407 | 7775414 |
View details of Evotec's funding rounds and investors
Evotec's founders and board of directors
Founder? Claim ProfileEvotec's employee count trend
Evotec has 4,767 employees as of Jun 26. Here is Evotec's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Evotec's Competitors and alternates
Top competitors of Evotec include Platinum Discovery. Here is the list of Top 10 competitors of Evotec, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | AI-driven life science company accelerating drug discovery and development | $25.1M | 76/100 | ||
2nd | Platinum Discovery 2019, Edinburgh (United Kingdom), Unfunded | Provider of multiomics research and precision medicine services | - | - | 18/100 |
Looking for more details on Evotec's competitors? Click here to see the top ones
Evotec's Investments and acquisitions
Evotec has made 23 investments in companies including Tubulis Technologies and Aeovian Pharmaceuticals. Evotec has also acquired 11 companies including Central Glass and Central Glass.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Mar 14, 2024 | Investments | 2015 | Munich (Germany) | |
Dec 22, 2023 | Investments | 2012 | San Francisco (United States) | |
Dec 01, 2022 | Investments | 2015 | Oxford (United Kingdom) |
See all investments and acquisitions by Evotec
Reports related to Evotec
Here is the latest report on Evotec's geography:
News related to Evotec
Media has covered Evotec for a total of 58 events in the last 1 year, 21 of them have been about company updates and 10 about people movement.
•
•
Evotec and Odyssey Therapeutics Form R&D Partnership for Autoimmune and Inflammatory DiseasesContract Pharma•Aug 07, 2026•Evotec, Odyssey
•
Niagen Bioscience Selects Evotec for Preclinical Development of Oral Small-Molecule CandidateContract Pharma•Aug 04, 2026•Evotec
•
Evotec chooses Navan to unify travel, payments and expense management globallyBusiness Wire•Jul 23, 2026•Navan, Evotec
•
Evotec Warns of Lowered Revenue and Profit Forecast, Stock Drops to Decade Lowmanager magazin•Jul 14, 2026•Evotec
•
Evotec Launches J.TRAIN to Deliver Turnkey Continuous Manufacturing for BiologicsPR Newswire•Jun 30, 2026•Evotec
•
•
•
Evotec Launches Strategic Review with Morgan Stanley and Moelis as Activist Investor CirclesAd Hoc News•May 31, 2026•Evotec
•
Are you a Founder ?
FAQs about Evotec
Explore our recently published companies
- Fabric - San Francisco based, 2022 founded, Funding Raised company
- Ambit Equity - Munich based, 2021 founded, Unfunded company
- A Malgam Technologies - Quebec City based, 2016 founded, Funding Raised company
- Billbo - Visakhapatnam based, Unfunded company
- Sooq Al Thahab - Manama based, 2022 founded, Funding Raised company
- Second Ocean - South Korea based, 2025 founded, Funding Raised company